128 related articles for article (PubMed ID: 38602061)
1. Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement.
Ito H; Takanashi M; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Makiyama K; Kobayashi K
Low Urin Tract Symptoms; 2024 May; 16(3):e12512. PubMed ID: 38602061
[TBL] [Abstract][Full Text] [Related]
2. Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study.
Pozzi E; Boeri L; Capogrosso P; Cazzaniga W; Candela L; Fallara G; Schifano N; Costa A; Cignoli D; Tutolo M; Matloob R; Abbate C; Montorsi F; Salonia A
Eur Urol Focus; 2022 Mar; 8(2):555-562. PubMed ID: 33757736
[TBL] [Abstract][Full Text] [Related]
3. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention.
Powell T; Staib L; Liu B; Bhatia S; Chai T; Ayyagari R
Urology; 2021 Oct; 156():216-224. PubMed ID: 33961894
[TBL] [Abstract][Full Text] [Related]
4. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of 180-W GreenLight laser photoselective vaporization of the prostate for storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors.
Hsieh YC; Wang CT; Kao YL; Cheng YS; Wu KY; Ho YH; Chuang MS; Huang YC; Ou YC
Neurourol Urodyn; 2024 Mar; 43(3):646-654. PubMed ID: 38314960
[TBL] [Abstract][Full Text] [Related]
6. Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.
Ahyai SA; Marik I; Ludwig TA; Becker A; Asdjodi S; Kluth L; Chun F; Fisch M; Schmid M
World J Urol; 2020 Dec; 38(12):3207-3217. PubMed ID: 32086571
[TBL] [Abstract][Full Text] [Related]
7. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression.
Gravas S; Palacios-Moreno JM; Thompson D; Concas F; Kamola PJ; Roehrborn CG; Oelke M; Kattan MW; Averbeck MA; Manyak M; Cortés V; Lulic Z
Eur Urol Focus; 2023 Jan; 9(1):178-187. PubMed ID: 35985933
[TBL] [Abstract][Full Text] [Related]
8. Postoperative Lower Urinary Tract Storage Symptoms: Does Prostate Enucleation Differ from Prostate Vaporization for Treatment of Symptomatic Benign Prostatic Hyperplasia?
Elkoushy MA; Elshal AM; Elhilali MM
J Endourol; 2015 Oct; 29(10):1159-65. PubMed ID: 25905430
[TBL] [Abstract][Full Text] [Related]
9. Change in Postoperative Storage Symptoms and
Castellani D; Di Rosa M; Saredi G; Pacchetti A; Banchero R; Ambrosini F; Meroni P; Guano G; Boltri M; Bucci S; Simonetti E; Maestroni UV; Ferretti S; Terrone C; Dellabella M
J Endourol; 2022 Sep; 36(9):1223-1230. PubMed ID: 35414264
[No Abstract] [Full Text] [Related]
10. Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.
Kwon T; Park S; Park S; Moon KH
Int Urol Nephrol; 2017 Jul; 49(7):1105-1110. PubMed ID: 28361474
[TBL] [Abstract][Full Text] [Related]
11. Improved lower urinary tract symptoms after robot-assisted radical prostatectomy: implications for survivorship, treatment selection and patient counselling.
Ahn T; Roberts MJ; Strahan A; Malone G; Paterdis J; Wood G; Heathcote P
BJU Int; 2019 May; 123 Suppl 5():47-53. PubMed ID: 31012991
[TBL] [Abstract][Full Text] [Related]
12. Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.
Elterman D; Li W; Hatiboglu G; Relle J; Zorn KC; Bhojani N; Chin J
J Endourol; 2021 Apr; 35(4):497-505. PubMed ID: 32935575
[No Abstract] [Full Text] [Related]
13. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
Jhang JF; Liao CH; Kuo HC
Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
[TBL] [Abstract][Full Text] [Related]
14. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
Cho MC; Yoo S; Park J; Cho SY; Son H; Oh SJ; Paick JS
BJU Int; 2019 May; 123(5A):E34-E42. PubMed ID: 30582661
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010060. PubMed ID: 30480763
[TBL] [Abstract][Full Text] [Related]
16. Is Holmium Laser Enucleation of Prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study.
Mostafa MM; Patil N; Khalil M; Elgammal MA; Mahdy A
Arch Ital Urol Androl; 2022 Jun; 94(2):174-179. PubMed ID: 35775342
[TBL] [Abstract][Full Text] [Related]
17. Correlation between prostatic urethral angulation and symptomatic improvement after surgery in patients with lower urinary tract symptoms according to prostate size.
Shim M; Bang WJ; Oh CY; Lee YS; Cho JS
World J Urol; 2020 Aug; 38(8):1997-2003. PubMed ID: 31646381
[TBL] [Abstract][Full Text] [Related]
18. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
[TBL] [Abstract][Full Text] [Related]
20. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
